Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Accelerating the Actionability of Treatment in Resected and Locally Advanced Pancreatic Cancer

NCT06574620 is registered in ClinicalTrials.gov with British Columbia Cancer Agency as lead sponsor.

NCT NCT06574620
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06574620 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Accelerating the Actionability of Treatment in Resected and Locally Advanced Pancreatic Cancer
Lead sponsor
British Columbia Cancer Agency
Phase
Not applicable
Overall status
Recruiting
Start date
November 28, 2025
Completion date
December 31, 2031
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

borderline resectable pancreatic ductal adenocarcinoma, locally advanced pancreatic ductal adenocarcinoma, pancreatic ductal adenocarcinoma, resectable pancreatic ductal adenocarcinoma